Understanding Genitourinary Syndrome of Menopause (GSM): Pathophysiology, Diagnosis, and Evidence-Based Care Genitourinary Syndrome of Menopause (GSM)—formerly referred to as vulvovaginal atrophy (VVA) or atrophic vaginitis—is a chronic, progressive medical condition that affects the vulva, vagina, urethra, and bladder trigone. In 2014, the International Society for the Study of Women’s Sexual Health (ISSWSH) and the North American Menopause...Read the full clinical guide: https://thewomenshealthclinic.co.uk/faqs/This clinical audio overview covers the latest standards in patient care and research.

Navigating Genitourinary Syndrome of Menopause (GSM): Symptoms, Biology, and Evidence-Based Treatments When discussing menopause, attention usually focuses on hot flushes, night sweats, and mood changes. However, over half of all postmenopausal women experience progressive, uncomfortable changes in lower genital and urinary tissues—a medical condition known as Genitourinary Syndrome of Menopause (GSM) or Vulvovaginal Atrophy (VVA). Unlike...Read the full clinical guide: https://thewomenshealthclinic.co.uk/faqs/This clinical audio overview covers the latest standards in patient care and research.

Understanding "Rejuvenation Burn": Why Local Vaginal Oestrogen Can Initially Sting, and How to Manage It When women transition through menopause, up to 84% experience Genitourinary Syndrome of Menopause (GSM)—historically referred to as vulvovaginal atrophy. GSM is a chronic, progressive condition caused by declining oestrogen levels. It causes distressing symptoms, including vaginal dryness, irritation, burning, soreness, painful intercourse...Read the full clinical guide: https://thewomenshealthclinic.co.uk/faqs/This clinical audio overview covers the latest standards in patient care and research.

Genitourinary Syndrome of Menopause (GSM): Understanding Your Body, Symptoms, and Modern Evidence-Based Treatments In 2014, the International Society for the Study of Women's Sexual Health (ISSWSH) and The Menopause Society (formerly NAMS) formally introduced the term Genitourinary Syndrome of Menopause (GSM). This comprehensive medical descriptor replaced older, narrower terms such as vulvovaginal atrophy (VVA) and atrophic vaginitis. Where...Read the full clinical guide: https://thewomenshealthclinic.co.uk/faqs/This clinical audio overview covers the latest standards in patient care and research.

Understanding Atrophic Rhinitis (Ozaena): Causes, Symptoms, and Evidence-Based Care Atrophic rhinitis is a chronic, debilitating inflammatory condition affecting the nasal cavity. Often referred to in clinical literature as ozaena, it causes progressive degeneration and thinning of the lining inside the nose, transforming healthy, moist respiratory tissue into dry, crusting surfaces. While less common in Western Europe than in the past, atrophic...Read the full clinical guide: https://thewomenshealthclinic.co.uk/faqs/This clinical audio overview covers the latest standards in patient care and research.

Understanding Genitourinary Syndrome of Menopause (GSM): Symptoms, Science, and Evidence-Based Solutions Genitourinary Syndrome of Menopause (GSM)—formerly referred to as vulvovaginal atrophy (VVA) or atrophic vaginitis—is a chronic, progressive, and highly prevalent condition affecting up to 84% of postmenopausal women. Despite its high prevalence, GSM is frequently under-diagnosed and under-treated, often because women mistakenly view the...Read the full clinical guide: https://thewomenshealthclinic.co.uk/faqs/This clinical audio overview covers the latest standards in patient care and research.

Read the full clinical guide: https://thewomenshealthclinic.co.uk/faqs/This clinical audio overview covers the latest standards in patient care and research for How do clinicians visually distinguish between localised petechiae from atrophy versus an active viral infection?.

Navigating Genitourinary Syndrome of Menopause (GSM): A Clinical Guide to Symptoms, Causes, and Evidence-Based Relief For many women, the menopausal transition is marked by well-known challenges such as hot flushes, night sweats, and mood changes. However, there is a second major set of changes that receives far less open discussion, despite affecting up to 50% to 80% of postmenopausal women: discomfort involving the vulva, vagina, bladder, and...Read the full clinical guide: https://thewomenshealthclinic.co.uk/faqs/This clinical audio overview covers the latest standards in patient care and research.

Understanding Chronic Mucosal Pale Discoloration (Pallor): Causes, Symptoms, and Modern Clinical Solutions By the Clinical Medical Editorial Team Medically reviewed in accordance with UK clinical standards and evidence-based pathology guidelines. --- What is Chronic Mucosal Pale Discoloration (Pallor)? Healthy mucosal membranes—the moist, protective linings covering the inside of your mouth, digestive tract, and genitourinary system—are...Read the full clinical guide: https://thewomenshealthclinic.co.uk/faqs/This clinical audio overview covers the latest standards in patient care and research.

Read the full clinical guide: https://thewomenshealthclinic.co.uk/faqs/This clinical audio overview covers the latest standards in patient care and research for How does sub-mucosal microvascular density decrease during chronic oestrogen deprivation?.